<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01033799</url>
  </required_header>
  <id_info>
    <org_study_id>NU207</org_study_id>
    <nct_id>NCT01033799</nct_id>
  </id_info>
  <brief_title>Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers</brief_title>
  <official_title>Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danone Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This single-center, randomized, double-blind and controlled study aims to examine the effect&#xD;
      of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001&#xD;
      (Actimel® = tested product) on the incidence of respiratory and gastro-intestinal common&#xD;
      infectious diseases (cumulated number of infections during the intervention period: primary&#xD;
      criteria), and on immune functions in healthy shift workers. Volunteers received either&#xD;
      200g/day of tested product (N=500) or control product (N=500) for 3-months, followed by a&#xD;
      1-month follow-up.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1000</enrollment>
  <condition>Infectious Diseases</condition>
  <condition>Healthy Subjects</condition>
  <condition>Respiratory Tract Infections</condition>
  <condition>Sore Throat</condition>
  <condition>Sinusitis</condition>
  <condition>Otitis</condition>
  <condition>Bronchitis</condition>
  <condition>Pneumonia</condition>
  <condition>Influenza</condition>
  <condition>Gastroenteritis</condition>
  <arm_group>
    <arm_group_label>Control Product</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Tested Product</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®)</intervention_name>
    <arm_group_label>Tested Product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non fermented dairy product (control)</intervention_name>
    <arm_group_label>Control Product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: male and female aged 18-65 years; working in 2- or 3-shift work&#xD;
        patterns (including night work); same job position for at least 4.5 months; a 19 to 30&#xD;
        kg/m2 body mass index; no symptoms of CIDs during the 2 weeks before product consumption;&#xD;
        agreeing to a written informed consent.&#xD;
&#xD;
        Exclusion criteria: part time work (&lt;90%); allergy/hypersensitivity to components of the&#xD;
        study product; severe respiratory allergy; a situation which, in the investigator's&#xD;
        opinion, could interfere with optimal participation or constitute a special risk for the&#xD;
        volunteer; a history of chronic metabolic/gastro-intestinal disease (except appendectomy);&#xD;
        surgery/intervention requiring general anesthesia in the last 4 weeks; administration of&#xD;
        systemic/topical treatments likely to interfere with the evaluation parameters in the last&#xD;
        4 weeks; chronic disease requiring antibiotics/antiseptics/anti-inflammatory medications;&#xD;
        special medicated diet; chronic/iatrogenic immunodeficiency; cardiac/renal/respiratory&#xD;
        insufficiency; severe evolutive/chronic pathology; pregnancy, breast feeding or lacking&#xD;
        effective contraception in females; susceptibility not to comply with dietary&#xD;
        recommendation during the study period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Harrisson Clinical Research Clinical Unit</name>
      <address>
        <city>München</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>December 16, 2009</study_first_submitted>
  <study_first_submitted_qc>December 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2009</study_first_posted>
  <last_update_submitted>January 18, 2017</last_update_submitted>
  <last_update_submitted_qc>January 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Probiotic - Lactobacillus casei DN114-001</keyword>
  <keyword>dairy product - infections - shiftworkers</keyword>
  <keyword>Common infectious diseases,</keyword>
  <keyword>occuring in healthy subjects,</keyword>
  <keyword>including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),</keyword>
  <keyword>lower respiratory tract infections (defined as bronchitis,</keyword>
  <keyword>pneumopathy and flu and flu-like syndromes), and</keyword>
  <keyword>gastrointestinal tract infection defined as gastroenteritis.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Pharyngitis</mesh_term>
    <mesh_term>Gastroenteritis</mesh_term>
    <mesh_term>Otitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

